MAP Health Management Reveals Compelling Addiction Treatment Outcomes Data in its First White Paper

May 17, 2016  

MAP Clinical Directors recap five years of outcomes data collection and look to the future of behavioral health.


MAP Health Management, the nation’s leader in the advancement of data-driven technology to improve clinical and financial outcomes in behavioral health, has released its first clinically-focused white paper. The paper, ‘Post-Treatment Recovery Support – The future of long-term recovery from addiction’, recaps MAP’s initial five years of outcomes data collection and points to the future of addiction treatment.

The paper serves as MAP’s foundational story and offers a comprehensive recap of the first five years of its operations. Due to its advanced algorithm-driven technologies and population health management platform, MAP has quickly established itself as a pioneer in the behavioral health space utilizing telehealth resources to improve the outcomes of people treated for addiction and substance use disorder.

“After many years of data gathering, we are happy to release our first white paper. In a rapidly changing field, what we have learned about the process of recovery, peer-to-peer support, assessing risk and intervening, as well as using a telehealth platform to provide recovery support and gather data is groundbreaking. Most importantly, the information and data presented in the paper represents individual lives saved and improved through extending the continuum of care”, commented co-author and MAP Clinical Director, Tom Kimball, Ph.D.

The paper showcases the rapid evolvement of the Austin based, data-driven company which has taken empirical outcomes data, interpreted the results, and has begun to demonstrate effective means in which treatment providers can extend the care continuum for discharged patients rendering successful treatment results. The data demonstrated by MAP has sparked the attention of major health insurance payers motivated to contain the rising costs of increased recidivism in addiction treatment and who have begun to express interest in reimbursing providers for extending the care continuum.

According to co-author and MAP Clinical Director, Kerby Stewart, M.D., “This is a breakthrough for the discipline of addiction management and an opportunity to dramatically expand effective recovery support. We have been able to document and enhance treatment efficacy not seen in this arena since the emergence of MAT.”

In addition to demonstrating game-changing outcomes data, the authors have set the stage for the future of addiction treatment and long-term, sustainable recovery. Based on the knowledge gleaned from its initial data gathering, MAP has evolved to delivering population health management solutions, predictive analytics, risk management and care coordination – all components to improving outcomes. From its position on the forefront of the behavioral health field, we can expect to see future white papers that expound on the importance of collecting and demonstrating outcomes data to addiction treatment providers, health insurance payers and healthcare consumers.

MAP’s white paper can be downloaded at

Loading Conversation